🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Ikos Cif LTD 13F Filings, Portfolio & Analysis

CIK: 0001372270
Limassol 1 Iacovou Tompazi Street 201 Vashiotis Business Centre
Zip Code: 3107
Latest Portfolio Value
$16.66 M
-42.44%
Total Holdings
133
7
Latest Report Date
Q3 2016
Top 10 Concentration
36.48%

Ikos Cif LTD — Portfolio Overview & Company Profile

Ikos Cif LTD (CIK: 0001372270) is a financial institution headquartered at 1 Iacovou Tompazi Street, 201 Vashiotis Business Centre, Limassol, Cyprus 3107. The firm regularly files Form 13F with the U.S. Securities and Exchange Commission (SEC), disclosing its equity holdings and investment positions.

As of the latest reporting period (2016-09-30), the institution manages a portfolio valued at $16.66 M, comprising 133 distinct securities. Over its filing history, it has submitted 15 Form 13F reports.

To view the institution’s full SEC filing history:
🔗 View All SEC Filings

Q3 2016 — Top-10 concentration: 36.5%. Quarterly turnover: 61.2%. ▲ 101 new, +9 added, −23 reduced, ×93 exited.

Portfolio Summary (Q3 2016)

Top Buys

Q3 2016
1. Nike
+$868,000
2. Goldman Sachs Group
+$828,000
3. Teva Pharmaceutical
+$766,000
4. General Electric
+$641,000
5. Marriott Intl INC Ne
+$604,000

Top Sells

Q3 2016
1. Mastercard
−$978,000
2. Ppl
−$877,000
3. Du Pont E I De Nemou
−$851,340.51
4. State Str
−$827,000
5. Mcdonald's
−$826,466.67

Asset Allocation

Stocks/ETFs
-40.85%
$16.66 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Top Stock & ETF Holdings (Q3 2016)

Name Shares Market Value Weight Change Activity
Nike
N/A
16,444 $868,000 5.21% ▲ 16,444 New Buy
Goldman Sachs Group
N/A
5,199 $828,000 4.97% ▲ 5,199 New Buy
Teva Pharmaceutical
N/A
16,171 $766,000 4.60% ▲ 16,171 New Buy
General Electric
N/A
21,300 $641,000 3.85% ▲ 21,300 New Buy
Marriott Intl INC Ne
N/A
8,982 $604,000 3.62% ▲ 8,982 New Buy
Baidu Com
N/A
2,897 $543,000 3.26% ▲ 2,897 New Buy
Applied Matls
N/A
17,083 $506,000 3.04% ▲ 17,083 New Buy
Dow Chem Co
N/A
8,840 $462,000 2.77% ▼ 12,107 Reduce -57.8%
Amgen
N/A
2,597 $437,000 2.62% ▲ 2,597 New Buy
Netease Com
N/A
1,735 $423,000 2.54% ▲ 1,735 New Buy

Historical Portfolio Charts